Literature DB >> 19545544

ATX-3, CDC-48 and UBXN-5: a new trimolecular complex in Caenorhabditis elegans.

Ana-João Rodrigues1, Andreia Neves-Carvalho, Anabela Ferro, Anne Rokka, Garry Corthals, Elsa Logarinho, Patrícia Maciel.   

Abstract

Ataxin-3 is the protein involved in Machado-Joseph disease, a neurodegenerative disorder caused by a polyglutamine expansion. Ataxin-3 binds ubiquitylated proteins and acts as a deubiquitylating enzyme in vitro. It was previously proposed that ataxin-3, along with the VCP/p97 protein, escorts ubiquitylated substrates for proteasomal degradation, although other players of this escort complex were not identified yet. In this work, we show that the Caenorhabditis elegans ataxin-3 protein (ATX-3) interacts with both VCP/p97 worm homologs, CDC-48.1 and CDC-48.2 and we map the interaction domains. We describe a motility defect in both ATX-3 and CDC-48.1 mutants and, in addition, we identify a new protein interactor, UBXN-5, potentially an adaptor of the CDC-48-ATX-3 escort complex. CDC-48 binds to both ATX-3 and UBXN-5 in a non-competitive manner, suggesting the formation of a trimolecular complex. Both CDC-48 and ATX-3, but not UBXN-5, were able to bind K-48 polyubiquitin chains, the standard signal for proteasomal degradation. Additionally, we describe several common interactors of ATX-3 and UBXN-5, some of which can be in vivo targets of this complex.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19545544     DOI: 10.1016/j.bbrc.2009.06.092

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

Review 2.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

3.  Dominant negative effect of polyglutamine expansion perturbs normal function of ataxin-3 in neuronal cells.

Authors:  Andreia Neves-Carvalho; Elsa Logarinho; Ana Freitas; Sara Duarte-Silva; Maria do Carmo Costa; Anabela Silva-Fernandes; Margarida Martins; Sofia Cravino Serra; André T Lopes; Henry L Paulson; Peter Heutink; João B Relvas; Patrícia Maciel
Journal:  Hum Mol Genet       Date:  2014-08-20       Impact factor: 6.150

4.  The Machado-Joseph disease deubiquitylase ATX-3 couples longevity and proteostasis.

Authors:  Kirsten Kuhlbrodt; Philipp Christoph Janiesch; Éva Kevei; Alexandra Segref; Roja Barikbin; Thorsten Hoppe
Journal:  Nat Cell Biol       Date:  2011-02-13       Impact factor: 28.824

Review 5.  Using C. elegans to decipher the cellular and molecular mechanisms underlying neurodevelopmental disorders.

Authors:  Carlos Bessa; Patrícia Maciel; Ana João Rodrigues
Journal:  Mol Neurobiol       Date:  2013-03-14       Impact factor: 5.590

6.  A monoclonal antibody toolkit for C. elegans.

Authors:  Gayla Hadwiger; Scott Dour; Swathi Arur; Paul Fox; Michael L Nonet
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

7.  Valosin-containing protein (VCP/p97) is an activator of wild-type ataxin-3.

Authors:  Mário N Laço; Luisa Cortes; Sue M Travis; Henry L Paulson; A Cristina Rego
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

8.  Absence of ataxin-3 leads to enhanced stress response in C. elegans.

Authors:  Ana João Rodrigues; Andreia Neves-Carvalho; Andreia Teixeira-Castro; Anne Rokka; Garry Corthals; Elsa Logarinho; Patrícia Maciel
Journal:  PLoS One       Date:  2011-04-19       Impact factor: 3.240

9.  Ataxin-3 plays a role in mouse myogenic differentiation through regulation of integrin subunit levels.

Authors:  Maria do Carmo Costa; Fernanda Bajanca; Ana-João Rodrigues; Ricardo J Tomé; Garry Corthals; Sandra Macedo-Ribeiro; Henry L Paulson; Elsa Logarinho; Patrícia Maciel
Journal:  PLoS One       Date:  2010-07-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.